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Martina Schröder and Andrew G. Bowie
Viral Immune Evasion Group, Department of Biochemistry, Trinity College Dublin, College Green, Dublin 2, IrelandToll-like receptor 3 (TLR3), which recognizes double-
stranded (ds)RNA, was the first identified antiviral TLR
and, because dsRNA is a universal viral molecular
pattern, TLR3 has been assumed to have a central role
in the host response to viruses. However, this role has
recently been questioned by in vivo studies and the
discovery of several other antiviral pattern-recognition
receptors. In this review, the function of TLR3 in the
context of these other receptors, namely TLR7, 8 and 9
and the newly identified dsRNA-receptor retinoic-acid
inducible gene-I (RIG-I) is discussed. Also, recent
research concerning the expression profile of TLR3, its
evasion by viruses and a potential role in crosspriming is
addressed, which reveals a clearer appreciation of the
contribution of TLR3 to antiviral immunity.Introduction
Toll-like receptors (TLRs) recognize different pathogen-
associated molecular patterns (PAMPs), leading to the
activation of an innate immune response and the shaping
of the subsequent adaptive immune response. The first
described ligands for TLRs were of bacterial origin, such
as lipopolysaccharide (for TLR4) or peptidoglycan (for
TLR2), but since the discovery of double-stranded (ds)
RNA as the ligand for TLR3 it has been recognized that
TLRs also have a role in the host defense against viruses
[1]. It is now clear that TLR3 can mediate responses to
the synthetic analog of viral dsRNA, polyriboinosinic:
polyribocytidylic acid [poly(I:C)], which has been used
extensively in experimental studies to mimic viral infec-
tion. Apart from constituting the genome of one class of
viruses, dsRNA is also generated during the life cycle of
most other viruses. Therefore, it has been assumed that
TLR3 would have a key role in antiviral immunity.
However, recent studies have questioned this [2], and it
is now clear that other TLRs, such as TLR7, 8 and 9, have
fundamental roles in the response to distinct viruses [3–8].
Furthermore, an additional pattern-recognition receptor
(PRR) for dsRNA, retinoic-acid inducible gene-I (RIG-I),
has recently been identified [9] and seems to be emerging
as a key player in the induction of an interferon response
by viruses. In this review, therefore, the current data on
TLR3 is summarized and an attempt to contextualize its
role in antiviral immunity is made.Corresponding author: Bowie, A.G. (agbowie@tcd.ie).
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Similar to TLR4 [10], engagement of the TLR3 signaling
pathway leads to the activation of two transcription
factors with central roles in innate immunity: NF-kB
and interferon (IFN)-regulatory factor 3 (IRF3) [11]. IRF
activation by TLRs is reviewed in detail by Moynagh, also
in this issue [12]. However, there are a few major differ-
ences compared to the other TLR signaling pathways. For
example, in contrast to all other known TLRs, TLR3 does
not recruit the adaptor molecule MyD88 but depends
solely on the alternative adaptor Toll–interleukin-1 (IL-1)
receptor-resistance (TIR) domain-containing adaptor
inducing IFN-b (TRIF) [13–16]. Furthermore, IL-1
receptor-associated kinase 1 (IRAK1) and IRAK4 are
also dispensable for TLR3 signaling [17]. Recently, it has
been demonstrated that TLR3 is phosphorylated at two
tyrosine residues on activation, and that phosphatidyl-
inositol 3-kinase (PI3K; PtdIns 3-kinase) is recruited
subsequently to these residues [18], a process that seems
to be required for full activation of IRF3 [19,20]. The only
other TLR that has been shown to be phosphorylated and
to recruit PI3K is TLR2 [21]; it therefore remains an open
question whether this mechanism also applies to the other
TLRs. The other essential step for IRF3 activation is
mediated by the recruitment of TANK [tumor necrosis
factor (TNF) receptor-associated factor (TRAF) family
member-associated NF-kB activator]-binding kinase-1
(TBK-1) to TRIF [11,22].
NF-kB activation seems to be at least partially medi-
ated by receptor-interacting protein-1 (RIP1) recruitment
[23]. TRAF6 has also been implicated in NF-kB activation
by TRIF [11,13,24]; however, its role has now been
questioned by a study usingmacrophages from TRAF6K/K
mice, in which activation of NF-kB by poly(I:C) was
normal in the knockout cells, as was induction of two
NF-kB-dependent genes [25]. Their results are in contrast
to the earlier results by Jiang et al., who found that
TRAF6 was required for NF-kB activation in murine
embryonic fibroblasts [13]. Therefore, the involvement of
TRAF6 in TRIF-induced NF-kB activation is controver-
sial, and it is possible that the requirement for TRAF6 is
cell-type specific or that TRAF6 and RIP1 mediate NF-kB
activation at different stages of the response. The
interaction with RIP1 also links TRIF to the apoptotic
cascade [26]. The pro-apoptotic effect is further mediated
by Fas-associated death domain (FADD) and caspase-8
and it is conceivable that RIP1 engages FADD through its
death domain [24,26]. The current knowledge of theReview TRENDS in Immunology Vol.26 No.9 September 2005. doi:10.1016/j.it.2005.07.002
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Figure 1.
TRIF is not a TLR3-specific adaptor molecule but is also
involved in IRF3 activation by TLR4. However, its recruit-
ment toTLR4 ismediatedbyanadditional adaptormolecule,
TRIF-related adaptor molecule (TRAM) [27]. Therefore, the
TRIFpathway is differentially activated byTLR3andTLR4.
Consistent with this, IFN-stimulated response element
induction by TLR4, but not by TLR3, requires the NF-kB
subunit p65 [28]. In addition, TLR3 engagement leads to a
much stronger induction of type I IFNs than does TLR4
signaling [29]. However, TBK1 mediates both TLR4- and
TLR3-induced IRF3 activation [30], so the observed differ-
ences between TLR3- and TLR4-induced IRF3 activation
might be quantitative rather than qualitative [31].
TLR3 in viral infection
The first study showing that TLR3 signaling was triggered
by dsRNA used not only poly(I:C) but also purified
genomic RNA from reovirus to stimulate the receptor [1].
Therefore, there is little doubt that TLR3 responds to viral
as well as to synthetic dsRNA. But what role does it have
in the response to viral infection? Because dsRNA is a
universal viral PAMP, it had been assumed that TLR3
would have a key role in antiviral immunity. Indeed, TLR3
has been implicated in the response to several viruses
[1,14,32–34], as discussed later.
Wang et al. demonstrated that, in infections with
the single-stranded (ss)RNA virus West Nile virus, aRip1
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Figure 1. The signaling pathways induced by TLR3. On dsRNA binding, TLR3 recruits
activation of IRF3 and NF-kB, and the initiation of an apoptotic cascade. TBK1 recruitmen
for the induction of type I interferons [13]. Another molecule involved in the full activatio
NF-kB activationwas originally thought to bemediated by TRAF6 [11,13] but it is now clea
of TRIF [23]. RIP1 also links TRIF to the apoptotic cascade [26], which is further mediated
itself induce apoptosis, similarly to RIP1. Therefore, it could act as a molecular switch be
[23,26]. Ultimately, TLR3 activation leads to the production of proinflammatory cytokines
protein kinase.
www.sciencedirect.comperipheral inflammatory response is initiated through
TLR3, leading to disruption of the blood–brain barrier,
which enables virus entry into the brain [34]. Therefore,
TLR3K/K mice were more resistant to lethal West Nile
virus infection, so that in this case the virus appeared to
benefit from its interaction with TLR3 [34]. TLR3 also
seems to be the TLR most strongly expressed in the brain,
specifically in astrocytes and glioblastoma cell lines
[35,36], and there has been a description of a TLR3 isoform
that seems to be exclusively expressed in the brain [36].
These findings might indicate that TLR3 has a specific
role in the brain and/or in the response to encephalitogenic
viruses but this should be further investigated.
Apart from this somewhat specific case, it was demon-
strated that cytokines are induced in a TLR3-dependent
manner in bronchial epithelial cell lines, on infection with
the ssRNA viruses respiratory syncytial virus or influ-
enza, although no animal models were used to verify a role
for TLR3 in vivo [32,33]. Interestingly, however, Rudd et al.
found that respiratory syncytial virus-inducedCXCL10 and
CCL5 production, but not CXCL8 production or viral
replication, were impaired in the absence of TLR3 [32].
It was shown that Lps2-mice, which have a loss-of-
function mutation in the Trif gene, show a higher rate of
mortality in murine cytomegalovirus (MCMV) infections
[14], and in a recent study, a role for TLR3 in the response
to MCMV was confirmed using TLR3K/K mice [6].
However, a study by Edelmann et al. questioned a
universal role for TLR3 in the antiviral response, claimingTRENDS in Immunology 
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the TIR adaptor molecule TRIF, which induces signaling pathways leading to the
t to the amino-terminal region of TRIF mediates IRF3 activation, which is important
n of IRF3 is PI3K, which is recruited to TLR3 on phosphorylation of the receptor [20].
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by FADD and caspase-8. RIP3 blocks TRIF-induced NF-kB activation, and can also by
tween the pathways leading from RIP1 to NF-kB-activation and apoptosis induction
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generation of a host adaptive immune response in MCMV,
vesicular stomatitis virus (VSV), lymphocytic chorio-
meningitis virus and reovirus infection [2]. Therefore,
the role of TLR3 in the response to viral infections, especi-
ally to MCMV infection, is controversial, and later a
potential role for TLR3 will be defined by comparing it
with other TLR-dependent and -independent antiviral
responses.
Alternative antiviral PRRs
With the discovery that unmethylated viral CpG-DNA
(from herpes simplex virus-2) can stimulate TLR9 [4]
and the identification of ssRNA (from influenza virus and
HIV-1) as the ligand for TLR7 [37,38], it seems that a
whole class of PRRs for viral nucleic acids is emerging.
TLR7 is involved in the response to the ssRNA viruses
VSV and influenza [5], whereas TLR9 has a role in
responding to the dsDNA viruses MCMV [6], herpes
simplex virus-1 (HSV-1) and HSV-2 [3,4,8].
Before the discovery of TLR3, it was well known that
cells detected viral dsRNA through dsRNA-dependent
protein kinase (PKR), which, in response, inhibits host
translation by phosphorylating the initiation factor, the a
subunit of eukaryotic protein synthesis initiation factor 2,
and, similar to TLR3, activates NF-kB [39]. Indeed, the
fact that PKRK/K cells still signaled in response to
poly(I:C) led to the identification of TLR3, which was
thought to provide the missing link [1]. However, it soon
became clear that cells must have yet additional mechan-
isms for the response to dsRNA with the finding that
TLR3K/K or TRIFK/K cells still showed a response to
poly(I:C) which could not be completely attributed to
PKR [40,41].
Yoneyama et al. identified the IFN-inducible DExD/H
box RNA helicase RIG-I as a novel intracellular PRR for
dsRNA [9]. Apart from its helicase domain, RIG-I also
contains a tandem caspase recruitment domain (CARD),
which transmits signals leading to NF-kB and IRF3
activation [9]. The authors demonstrated that RIG-I is
essential for IFN induction by Newcastle disease virus
and this also seems to be the case for Sendai and hepatitis
C virus (HCV) infections [42,43]. Furthermore, replication
of VSV and encephalomyocarditis virus was inhibited in
RIG-I overexpressing cells [9]. The RIG-I pathway seems
to be independent of the TLR3 pathway because a
dominant negative form of RIG-I did not block TLR3- or
TRIF-induced IRF3 activation. Similarly, TRIF and TLR3
were found to be dispensable for RIG-I signaling [9]. It is
likely that RIG-I interacts with other CARD domain-
containing proteins to relay its signaling; however, these
remain to be identified. Along with RIG-I, a homologous
CARD domain-containing helicase, melanoma differen-
tiation-associated gene-5 (mda-5), was identified and
shown to have similar effects in dsRNA signaling [9].
Therefore, the response to dsRNA is multifaceted and is
likely to become even more complex. Notably, a mouse
locus that had been identified to confer TRIF-independent
responsiveness to poly(I:C) [41] does not correspond to
either RIG-I or mda-5 [9]. Therefore, this gene product
might either function in the RIG-I pathway, or representwww.sciencedirect.comyet another independent mechanism for the response to
dsRNA.
Given the reports described earlier, it has become more
difficult to define a specific role for TLR3 in the antiviral
response. It is probable that viral infections, similar to
bacterial infections, produce a multitude of ligands that
act on different TLRs or non-TLR PRRs. Therefore, it
could be simply the redundancy in the viral detection
system that makes it difficult to pinpoint a role for one
specific component. However, there are now clear roles for
TLR7, TLR9 and RIG-I in antiviral responses. So, is TLR3
just not as important? Arguing against this assumption
would be the fact that we and others have recently
identified viral evasion mechanisms targeting the TLR3
pathway, and it is generally assumed that viruses, in a
process of highly efficient coevolution with the host, target
the key mechanisms of the antiviral response.
Viral evasion of the TLR3 pathway
Wehave shown recently that vaccinia virus (VV), a dsDNA
virus, expresses two proteins, A46R and A52R, which
target different aspects of the TLR3 signaling pathway
and thereby inhibit TLR3-induced gene induction effi-
ciently. Whereas A46R, a TIR domain-containing protein,
binds to TRIF directly and inhibits poly(I:C)-induced IRF3
activation, A52R potently blocks TLR3 signaling, leading
to NF-kB activation [44,45]. Interesting in this context is
that VV replicates to a higher titer in macrophages
derived from Lps2 mice [14], which implicates TRIF in
the antiviral IFN response to VV, leading to the inhibition
of viral replication.
Also, NS3–4a, a protease from HCV, besides targeting
some as yet unknown component of the RIG-I pathway
[43,46], has been described recently to cleave TRIF
specifically, thereby abrogating TLR3 signaling [47,48].
Therefore, it seems important for the virus to disrupt not
only the RIG-I but also the TLR3 pathway. However, it
should be noted that TRIF is also necessary for IFN
induction by TLR4. Thus, certain viruses could benefit
from targeting TRIF through preventing IFN induction by
opportunistic bacterial infections, which would engage
TLR4.
Role of TLR3 in viral detection: does location hold the
key?
It is likely that the intracellular localization and cellular
expression pattern of TLR3, as compared with that of
RIG-I and TLR7, 8 and 9, will provide a key to answering
the question about its specific role in the antiviral
response. TLR3 localizes to an intracellular vesicular
compartment in dendritic cells (DCs) and cannot be
detected on the cell surface [49]. This compartment has
been assumed to be endosomal because inhibition of endo-
somal acidification abrogates poly(I:C) signaling. How-
ever, Matsumoto et al. failed to see co-localization of TLR3
with endosomal or, indeed, any other organelle markers
tested [49]; the exact nature of the TLR3-containing
vesicles therefore needs to be clarified. In any case,
TLR3 has to encounter dsRNA in these vesicles, which is
probably achieved through phagocytosis of dsRNA
released into the extracellular space by necrotic or virally
Review TRENDS in Immunology Vol.26 No.9 September 2005 465lysed cells. The other possible scenario would be the
exposure of a dsRNA genome during viral entry through
receptor-mediated endocytosis. In contrast to TLR3, PKR,
RIG-I and mda-5 are cytoplasmic and therefore much
more suited for the direct recognition of dsRNA produced
during viral replication. For the establishment of an
adaptive immune response against virus-infected cells, it
is crucial to induce DCmaturation. Therefore, the relative
contribution of RIG-I versus TLR3 for the response to a
particular virusmight, among other factors, depend on the
ability of the virus to infect DCs. It is conceivable that the
host response to a virus, such as Sendai virus, which
infects DCs and enters the cell by plasma membrane
fusion (thereby avoiding the endosomes), would rather
depend on RIG-I. In fact, the host response to Sendai virus
is completely independent of TLR3, 7, 8 or 9 [50] and is
mediated by RIG-I [43].
It is probable, however, that dsRNA, during the course
of a viral infection, comes into contact with both the
cytoplasmic receptors and TLR3. So, why does a cell need
different mechanisms to recognize dsRNA? This is
particularly perplexing because the signaling pathways
elicited by TLR3, PKR and RIG-I overlap significantly, in
that all three activate NF-kB, whereas RIG-I and TLR3
(and possibly also PKR) activate IRF3 and IRF7 [9,13,39].
RIG-I and TLR3 even seem to depend on the same kinases,
IKK-3 and TBK1, to phosphorylate IRF3 [51,52]. Further-
more, apoptosis, is induced not only by TLR3 but also by
PKR and probably by RIG-I [26,53–56]. Interestingly,
however, different gene profiles are induced by poly(I:C)
stimulation (through TLR3) or Sendai virus infection
(through RIG-I), with only a couple of genes similarly
induced by both pathways [57]. Therefore, it is probable
that subtle differences exist in the signaling pathways of
TLR3, PKR and RIG-I, which will, on further investi-
gation, provide more insights into the specific roles of
these dsRNA receptors.
Different TLRs for different DC populations
Whereas TLR3 displays a distinct intracellular localiza-
tion compared with RIG-I and PKR, it is striking that
TLR3, 7, 8 and 9 show a similar intracellular localization,
and it therefore appears that they are all designed to
detect viral nucleic acids in endosomal compartments.
However, they are expressed by different DC populations:
TLR3 is not expressed in plasmacytoid DCs (pDCs), which
express high levels of TLR7 and TLR9. By contrast, TLR3
is expressed in myeloid DCs, specifically in human
monocyte-derived DCs and CD11C blood DCs, as well as
in murine CD8aC DCs. Importantly, this differential
expression profile is reflected in distinct gene induction
patterns: pDCs produce high amounts of type I IFNs
(predominantly IFN-a) in response to TLR7 or TLR9
engagement, whereas myeloid DCs mainly produce IL-12
and IFN-b on TLR3 stimulation [58–60] (Figure 2). It is
therefore possible to imagine that different DC subtypes
are involved in different stages of the antiviral response.
For example, TLR7 and TLR9 might trigger a quick IFN
response, whereas TLR3 might be more important for a
prolonged response and the initiation of the adaptive
immune response. In this context, it is interesting to notewww.sciencedirect.comthat, in MCMV infection, IL-12 production seemed to be
more dependent on TLR3, compared with type I IFN
production [6]. Concerning the expression of TLRs, there
appears to be some divergence between the murine and
the human system; for example, murine, but not human,
myeloid DCs express TLR9. This could mean that there is
less redundancy in the human viral detection system, and
it certainly means that data obtained in murine knockout
models must be interpreted carefully with respect to the
human system [58–61].
TLR3 on natural killer (NK) cells
NK cells are major players in the antiviral immune
response and express TLR3 and are activated directly in
response to poly(I:C) [62–64]. This could represent
another important function for TLR3, especially in virus
infections that heavily rely on NK cells for clearance
(Figure 2). This is the case for MCMV infections, and,
indeed, TLR3 contributes to the response to this virus [6].
However, NK cells also seem to be able to respond directly
to other viral TLR stimuli, such as CpG-DNA [64]. There-
fore, activation of NK cells might not be a unique feature
of TLR3 but might similarly apply to TLR9 and possibly
TLR7 and 8.
Crosspriming: a more specific role for TLR3
In the case of viruses that have no tropism for DCs, the
immune system relies on crosspresentation and cross-
priming for the initiation of a CD8C T-cell response
against the infected tissue cells. Viral antigens from these
cells have to be crosspresented by antigen-presenting cells
(APCs) and virally infected cells have to provide a DC
maturation signal (crosspriming). Schulz et al. suggested
recently that TLR3 has an important role in crosspriming
[65]. They showed that poly(I:C)-transfected tissue cells
stimulated the upregulation of co-stimulatory molecules
on DCs more efficiently than free poly(I:C); this was
attributed to a different uptake mechanism for the
poly(I:C)-containing cells. Moreover, Semliki forest virus-
or encephalomyocarditis virus-infected cells induced DC
activation efficiently in this system, showing that biologi-
cal levels of dsRNA intermediates are sufficient for this
response. By using TLR3K/K mice, the authors demon-
strated that this crosspriming mechanism is mediated
largely by TLR3. It had been suggested previously that
TLR3 and TLR9, but not other TLRs, can mediate cross-
presentation and -priming [66,67].
In this context, it should be mentioned that Sato and
Iwasaki have shown that TLR signaling through MyD88
is required for the optimal induction of a Th1 response
against HSV-2 in both the infected tissue cells and the
non-infected DCs [68]. A similar two-step model could
apply for the recognition of dsRNA by TLR3. In fact, Lebre
et al. demonstrated that the supernatant from poly(I:C)-
stimulated keratinocytes can prime DCs to induce a Th1
response [69]. Furthermore, type I IFNs, released from
virally infected tissue cells, can also promote the cross-
priming of DCs [70] (Figure 2), a mechanism that was
prevented in the experimental model of Schulz et al. [65].
Therefore, it is possible that TLR3 has a more prominent
role in the response to viruses that interfere successfully
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Figure 2. The immune response to viral nucleic acids. Viral nucleic acids are recognized by distinct PRRs expressed in different cell types. DCs take center stage in this
response, as they are crucial for initiating an adaptive immune response. (a) Plasmacytoid DCs express TLR7 and TLR9, which recognize viral ssRNA and CpG-DNA,
respectively, in an endosomal compartment. The viral nucleic acids are likely to be released from virally infected tissue cells and to be taken up through phagocytosis by the
DCs. The engagement of TLR7 or TLR9 on pDCs leads to the production of type I IFNs, particularly IFN-a. (b) By contrast, TLR3 is expressed by myeloid DCs, which produce
mainly IFN-b and IL-12 on stimulation by dsRNA [59,60]. The dsRNA can also either originate from lysed infected cells or it can be taken up in a cell-associated form, which
induces a stronger DC maturation signal (upregulation of co-stimulatory molecules). The latter event leads to crosspriming, which is necessary to induce a CD8C T-cell
response to infected tissue cells [65]. (c) In contrast to TLR3, RIG-I is expressed in the cytoplasm of cells and is therefore more suited for the recognition of dsRNA produced
during viral replication [9]. Therefore, a virally infected DC can directly induce DCmaturation through RIG-I, circumventing a role for TLR3. (d) DsRNA can also be recognized
by tissue cells through either TLR3 or RIG-I, leading to the production of cytokines and IFNs, which can activate DCs, promote crosspriming and shape the adaptive immune
response [69,70]. (e) Furthermore, NK cells have been shown to be directly activated by dsRNA (and CpG-DNA), which can lead to enhanced killing of virus-infected cells by
the NK cells [62–64]. Therefore, the response to the pathogen-associated molecular patterns produced by a virus is complex and is mediated by a range of different PRRs and
cell types. There is likely to be a certain redundancy in the system; however, it is also clear that distinct PRRs mediate specific aspects of the antiviral response.
Review TRENDS in Immunology Vol.26 No.9 September 2005466with IFN production [65], which is a common viral evasion
strategy.
Future perspectives
The specific role of TLR3 in the complex picture of the
antiviral response is still largely unclear. MediatingBox 1. Factors that influence the relevance of TLR3 for an
antiviral response
The relative contribution of TLR3 to the host response against a virus
might depend on the following factors:
† Tropism of the virus (tissue cells or APCs?)
† Entry route of the virus (via endosomes or plasma membrane?)
† Localization of dsRNA (genome or replication intermediates) in
the cell
† Nature of dsRNA in the cell: is it coated or packaged?
† Abundance of dsRNA intermediates produced during replication
cycle
† Production of type I IFNs by virally infected tissue cells (does the
virus have the means to interfere with IFN production?)
† Role of NK cells in the clearance of the virus
www.sciencedirect.comcrosspriming might turn out to be the ‘unique selling
point’ of TLR3, considering that TLR9 is not expressed on
humanmyeloid DCs, and therefore probably has no role in
crosspriming in humans. Some factors that can influence
the relative relevance of TLR3 versus cytoplasmic dsRNA
PRRs are summarized in Box 1. The roles of the different
DC populations in antiviral immunity (and in general)
have not yet been clarified sufficiently, however, they are
likely to hold important insights, considering the rela-
tively clear-cut expression pattern of TLRs. Furthermore,
a detailed investigation of the signaling pathways and the
gene profiles induced by TLR3 and RIG-I will provide us
with a better understanding of their respective roles.
Open questions regarding the molecular aspects of the
response to dsRNA are summarized in Box 2. It is also
probable that we do not yet know the full picture of the
response to dsRNA, and that additional players will be
discovered. However, the fact that two distinct viruses, VV
and HCV, have now been demonstrated to possess evasion
strategies targeting the TLR3 pathway, strongly suggests
Box 2. Unresolved issues regarding the molecular response
to dsRNA
Is TRAF6 involved in TLR3-mediated signaling to NF-kB?
Are there additional TRIF-independent components in the TLR3
pathway?
Are there additional cytoplasmic dsRNA receptors?
Do the pathways recognizing dsRNA display some crosstalk
(e.g. involvement of PKR or mda-5 in TLR3 signaling) [17,71]?
What is the gene product of the identifiedmouse locus implied in the
TLR3- and PKR-independent response to dsRNA [41]?
How do the signals elicited by TLR3 and RIG-I differ?
Review TRENDS in Immunology Vol.26 No.9 September 2005 467that our appreciation of the role of TLR3 in the antiviral
response can only grow.Acknowledgements
Work in our laboratory is supported by Science Foundation Ireland, The
Health Research Board and the Irish Research Council for Science,
Education and Technology (IRCSET).References
1 Alexopoulou, L. et al. (2001) Recognition of double-stranded RNA and
activation of NF-kB by Toll-like receptor 3. Nature 413, 732–738
2 Edelmann, K.H. et al. (2004) Does Toll-like receptor 3 play a biological
role in virus infections? Virology 322, 231–238
3 Hochrein, H. et al. (2004) Herpes simplex virus type-1 induces IFN-a
production via Toll-like receptor 9-dependent and -independent
pathways. Proc. Natl. Acad. Sci. U. S. A. 101, 11416–11421
4 Lund, J. et al. (2003) Toll-like receptor 9-mediated recognition of
Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med.
198, 513–520
5 Lund, J.M. et al. (2004) Recognition of single-stranded RNAviruses by
Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 101, 5598–5603
6 Tabeta, K. et al. (2004) Toll-like receptors 9 and 3 as essential
components of innate immune defense against mouse cytomegalovirus
infection. Proc. Natl. Acad. Sci. U. S. A. 101, 3516–3521
7 Krug, A. et al. (2004) TLR9-dependent recognition of MCMV by IPC
and DC generates coordinated cytokine responses that activate
antiviral NK cell function. Immunity 21, 107–119
8 Krug, A. et al. (2004) Herpes simplex virus type 1 activates murine
natural interferon-producing cells through Toll-like receptor 9. Blood
103, 1433–1437
9 Yoneyama, M. et al. (2004) The RNA helicase RIG-I has an essential
function in double-stranded RNA-induced innate antiviral responses.
Nat. Immunol. 5, 730–737
10 Takeda, K. and Akira, S. (2004) TLR signaling pathways. Semin.
Immunol. 16, 3–9
11 Sato, S. et al. (2003) Toll/IL-1 receptor domain-containing adaptor
inducing IFN-b (TRIF) associates with TNF receptor-associated factor
6 and TANK-binding kinase 1, and activates two distinct transcription
factors, NF-kB and IFN-regulatory factor-3, in the Toll-like receptor
signaling. J. Immunol. 171, 4304–4310
12 Moynagh, P.N. TLR signalling and activation of IRFs: revisiting old
friends from the NF-kB pathway. Trends Immunol. (in press) doi:
10.1016/j.it.2005.06.009
13 Jiang, Z. et al. (2004) Toll-like receptor 3-mediated activation of NF-kB
and IRF3 diverges at Toll–IL-1 receptor domain-containing adapter
inducing IFN-b. Proc. Natl. Acad. Sci. U. S. A. 101, 3533–3538
14 Hoebe, K. et al. (2003) Identification of Lps2 as a key transducer of
MyD88-independent TIR signalling. Nature 424, 743–748
15 Yamamoto, M. et al. (2003) Role of adaptor TRIF in the MyD88-
independent Toll-like receptor signaling pathway. Science 301,
640–643
16 Oshiumi, H. et al. (2003) TICAM-1, an adaptor molecule that partici-
pates in Toll-like receptor 3-mediated interferon-b induction. Nat.
Immunol. 4, 161–167
17 Jiang, Z. et al. (2003) Poly(I-C)-induced Toll-like receptor 3 (TLR3)-
mediated activation of NFkB and MAP kinase is through anwww.sciencedirect.cominterleukin-1 receptor-associated kinase (IRAK)-independent path-
way employing the signaling components TLR3–TRAF6–TAK1–
TAB2–PKR. J. Biol. Chem. 278, 16713–16719
18 Sarkar, S.N. et al. (2003) Double-stranded RNA signaling by Toll-like
receptor 3 requires specific tyrosine residues in its cytoplasmic
domain. J. Biol. Chem. 278, 4393–4396
19 Sen, G.C. and Sarkar, S.N. (2005) Transcriptional signaling by double-
stranded RNA: role of TLR3. Cytokine Growth Factor Rev. 16, 1–14
20 Sarkar, S.N. et al. (2004) Novel roles of TLR3 tyrosine phosphorylation
and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol.
Biol. 11, 1060–1067
21 Arbibe, L. et al. (2000) Toll-like receptor 2-mediated NF-kB activation
requires a Rac1-dependent pathway. Nat. Immunol. 1, 533–540
22 Fitzgerald, K.A. et al. (2003) IKK3 and TBK1 are essential components
of the IRF3 signaling pathway. Nat. Immunol. 4, 491–496
23 Meylan, E. et al. (2004) RIP1 is an essential mediator of Toll-like
receptor 3-induced NF-kB activation. Nat. Immunol. 5, 503–507
24 Han, K.J. et al. (2004) Mechanisms of the TRIF-induced interferon-
stimulated response element and NF-kB activation and apoptosis
pathways. J. Biol. Chem. 279, 15652–15661
25 Gohda, J. et al. (2004) Cutting edge: TNFR-associated factor (TRAF) 6
is essential for MyD88-dependent pathway but not Toll/IL-1 receptor
domain-containing adaptor-inducing IFN-b (TRIF)-dependent path-
way in TLR signaling. J. Immunol. 173, 2913–2917
26 Kaiser, W.J. and Offermann, M.K. (2005) Apoptosis induced by the
Toll-like receptor adaptor TRIF is dependent on its receptor
interacting protein homotypic interaction motif. J. Immunol. 174,
4942–4952
27 Oshiumi, H. et al. (2003) TIR-containing adapter molecule (TICAM)-2,
a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that
induces interferon-b. J. Biol. Chem. 278, 49751–49762
28 Wietek, C. et al. (2003) Interferon regulatory factor-3-mediated
activation of the interferon-sensitive response element by Toll-like
receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kB.
J. Biol. Chem. 278, 50923–50931
29 Doyle, S.E. et al. (2003) Toll-like receptor 3 mediates a more potent
antiviral response thanToll-like receptor 4.J. Immunol.170, 3565–3571
30 McWhirter, S.M. et al. (2004) IFN-regulatory factor 3-dependent gene
expression is defective in Tbk1-deficient mouse embryonic fibroblasts.
Proc. Natl. Acad. Sci. U. S. A. 101, 233–238
31 Servant, M.J. et al. (2003) Identification of the minimal phospho-
acceptor site required for in vivo activation of interferon regulatory
factor 3 in response to virus and double-stranded RNA. J. Biol. Chem.
278, 9441–9447
32 Rudd, B.D. et al. (2005) Differential role for TLR3 in respiratory
syncytial virus-induced chemokine expression. J. Virol. 79, 3350–3357
33 Guillot, L. et al. (2005) Involvement of Toll-like receptor 3 in the
immune response of lung epithelial cells to double-stranded RNA and
influenza A virus. J. Biol. Chem. 280, 5571–5580
34 Wang, T. et al. (2004) Toll-like receptor 3mediatesWest Nile virus entry
into the brain causing lethal encephalitis.Nat. Med. 10, 1366–1373
35 Farina, C. et al. (2005) Preferential expression and function of Toll-like
receptor 3 in human astrocytes. J. Neuroimmunol. 159, 12–19
36 Yang, E. et al. (2004) Cloning of TLR3 isoform. Yonsei Med. J. 45,
359–361
37 Diebold, S.S. et al. (2004) Innate antiviral responses by means of
TLR7-mediated recognition of single-stranded RNA. Science 303,
1529–1531
38 Heil, F. et al. (2004) Species-specific recognition of single-stranded
RNA via Toll-like receptor 7 and 8. Science 303, 1526–1529
39 Saunders, L.R. and Barber, G.N. (2003) The dsRNA binding
protein family: critical roles, diverse cellular functions. FASEB J.
17, 961–983
40 Diebold, S.S. et al. (2003) Viral infection switches non-plasmacytoid
dendritic cells into high interferon producers. Nature 424, 324–328
41 Hoebe, K. et al. (2003) Upregulation of costimulatory molecules
induced by lipopolysaccharide and double-stranded RNA occurs by
Trif-dependent and Trif-independent pathways. Nat. Immunol. 4,
1223–1229
42 Sumpter, R., Jr. et al. (2005) Regulating intracellular antiviral defense
and permissiveness to hepatitis C virus RNA replication through a
cellular RNA helicase, RIG-I. J. Virol. 79, 2689–2699
Review TRENDS in Immunology Vol.26 No.9 September 200546843 Foy, E. et al. (2005) Control of antiviral defenses through hepatitis C
virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl.
Acad. Sci. U. S. A. 102, 2986–2991
44 Harte, M.T. et al. (2003) The poxvirus protein A52R targets Toll-like
receptor signaling complexes to suppress host defense. J. Exp. Med.
197, 343–351
45 Stack, J. et al. (2005) Vaccinia virus protein A46R targets multiple
Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
J. Exp. Med. 201, 1007–1018
46 Breiman, A. et al. (2005) Inhibition of RIG-I-dependent signaling to
the interferon pathway during hepatitis C virus expression and
restoration of signaling by IKK3. J. Virol. 79, 3969–3978
47 Ferreon, J.C. et al. (2005) Molecular determinants of TRIF proteolysis
mediated by the hepatitis C virus NS3/4A protease. J Biol Chem. 280,
20483–20492
48 Li, K. et al. (2005) Immune evasion by hepatitis C virus NS3/4A
protease-mediated cleavage of the Toll-like receptor 3 adaptor protein
TRIF. Proc. Natl. Acad. Sci. U. S. A. 102, 2992–2997
49 Matsumoto, M. et al. (2003) Subcellular localization of Toll-like
receptor 3 in human dendritic cells. J. Immunol. 171, 3154–3162
50 Lopez, C.B. et al. (2004) TLR-independent induction of dendritic cell
maturation and adaptive immunity by negative-strand RNA viruses.
J. Immunol. 173, 6882–6889
51 Hemmi, H. et al. (2004) The roles of two IkB kinase-related kinases in
lipopolysaccharide and double stranded RNA signaling and viral
infection. J. Exp. Med. 199, 1641–1650
52 Perry, A.K. et al. (2004) Differential requirement for TANK-binding
kinase-1 in type I interferon responses to Toll-like receptor activation
and viral infection. J. Exp. Med. 199, 1651–1658
53 Gil, J. and Esteban, M. (2000) Induction of apoptosis by the
dsRNA-dependent protein kinase (PKR): mechanism of action.
Apoptosis 5, 107–114
54 Hsu, L.C. et al. (2004) The protein kinase PKR is required for
macrophage apoptosis after activation of Toll-like receptor 4. Nature
428, 341–345
55 Iordanov, M.S. et al. (2005) Recruitment of TRADD, FADD, and
caspase 8 to double-stranded RNA-triggered death inducing signaling
complexes (dsRNA–DISCs). Apoptosis 10, 167–176
56 Matsumoto, S. et al. (2005) Analysis of dsRNA-induced apoptosis
pathways using IFN response-noninducible siRNA-expression vector
library.J.Biol.Chem.DOI: 10.1074/jbc.M412784200(http://intl.jbc.org/)
57 Elco, C.P. et al. (2005) Analysis of genes induced by Sendai virus
infection of mutant cell lines reveals essential roles of interferonFree journals for dev
The WHO and six medical journal publishers have launched the Acc
poorest countries to gain free access to bio
The science publishers, Blackwell, Elsevier, the Harcourt Worldwide
Springer-Verlag and JohnWiley,were approachedby theWHOand th
will be available for free or at significantly reduced prices to universitie
countries. The second stage involves extending t
Gro HarlemBrundtland, director-general for theWHO, said that this in
the health information gap betw
See http://www.healthinternetw
www.sciencedirect.comregulatory factor 3, NF-kB, and interferon but not Toll-like receptor 3.
J. Virol. 79, 3920–3929
58 Degli-Esposti, M.A. and Smyth, M.J. (2005) Close encounters of
different kinds: dendritic cells and NK cells take centre stage. Nat.
Rev. Immunol. 5, 112–124
59 Reis e Sousa, C. (2004) Toll-like receptors and dendritic cells: for whom
the bug tolls. Semin. Immunol. 16, 27–34
60 Ito, T. et al. (2002) Roles of Toll-like receptors in natural interferon-
producing cells as sensors in immune surveillance. Hum. Immunol.
63, 1120–1125
61 Wagner, H. (2004) The immunobiology of the TLR9 subfamily. Trends
Immunol. 25, 381–386
62 Pisegna, S. et al. (2004) p38 MAPK activation controls the TLR3-
mediated up-regulation of cytotoxicity and cytokine production in
human NK cells. Blood 104, 4157–4164
63 Schmidt, K.N. et al. (2004) APC-independent activation of NK cells by
the Toll-like receptor 3 agonist double-stranded RNA. J. Immunol.
172, 138–143
64 Sivori, S. et al. (2004) CpG and double-stranded RNA trigger human
NK cells by Toll-like receptors: induction of cytokine release and
cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci.
U. S. A. 101, 10116–10121
65 Schulz, O. et al. (2005) Toll-like receptor 3 promotes cross-priming to
virus-infected cells. Nature 433, 887–892
66 Fujimoto, C. et al. (2004) Polyriboinosinic polyribocytidylic acid
[poly(I:C)]/TLR3 signaling allows class I processing of exogenous
protein and induction of HIV-specific CD8C cytotoxic T lymphocytes.
Int. Immunol. 16, 55–63
67 Datta, S.K. et al. (2003) A subset of Toll-like receptor ligands
induces cross-presentation by bone marrow-derived dendritic cells.
J. Immunol. 170, 4102–4110
68 Sato, A. and Iwasaki, A. (2004) Induction of antiviral immunity
requires Toll-like receptor signaling in both stromal and dendritic cell
compartments. Proc. Natl. Acad. Sci. U. S. A. 101, 16274–16279
69 Lebre, M.C. et al. (2003) Double-stranded RNA-exposed human
keratinocytes promote Th1 responses by inducing a type-1 polarized
phenotype in dendritic cells: role of keratinocyte-derived tumor
necrosis factor a, type I interferons, and interleukin-18. J. Invest.
Dermatol. 120, 990–997
70 Le Bon, A. et al. (2003) Cross-priming of CD8C T cells stimulated by
virus-induced type I interferon. Nat. Immunol. 4, 1009–1015
71 Li, K. et al. (2005) Distinct poly(I-C) and virus-activated signaling
pathways leading to interferon-b production in hepatocytes. J Biol
Chem. 280, 16739–16747eloping countries
ess to Research Initiative, which enables nearly 70 of the world’s
medical literature through the Internet.
STM group, Wolters Kluwer International Health and Science,
eBritishMedical Journal in 2001. Initially,more than 1000 journals
s,medical schools, research and public institutions in developing
his initiative to institutions in other countries.
itiativewas ’perhaps the biggest step ever taken towards reducing
een rich and poor countries’.
ork.net for more information.
